GenMark Diagnostics, Inc. - FORM 10-K - EX-23.1 - CONSENT OF DELOITTE & TOUCHE LLP (US) - March 21, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - GenMark Diagnostics, Inc.Financial_Report.xls
EX-10.18 - SETTLEMENT AND RELEASE AGREEMENT - GenMark Diagnostics, Inc.d270238dex1018.htm
EX-10.21 - FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT - GenMark Diagnostics, Inc.d270238dex1021.htm
EX-10.2 - FIRST AMENDMENT TO LEASE - GenMark Diagnostics, Inc.d270238dex102.htm
EX-10.26 - EXECUTIVE EMPLOYMENT AGREEMENT - GenMark Diagnostics, Inc.d270238dex1026.htm
EX-10.23 - THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT - GenMark Diagnostics, Inc.d270238dex1023.htm
EX-23.2 - CONSENT OF DELOITTE LLP (UK) - GenMark Diagnostics, Inc.d270238dex232.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - GenMark Diagnostics, Inc.d270238dex311.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - GenMark Diagnostics, Inc.d270238dex312.htm
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - GenMark Diagnostics, Inc.d270238dex321.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - GenMark Diagnostics, Inc.d270238dex322.htm
10-K - FORM 10-K - GenMark Diagnostics, Inc.d270238d10k.htm
EX-10.22 - SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT - GenMark Diagnostics, Inc.d270238dex1022.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration No. 333-178301 on Form S-3 and Registration Statement No. 333-168892 on Form S-8 of our reports dated March 20, 2012, relating to the consolidated financial statements of GenMark Diagnostics, Inc. and subsidiaries (the “Company”) (formerly Osmetech plc and subsidiaries), and the effectiveness of the Company’s internal control over financial reporting (which report expressed an adverse opinion on the effectiveness of the Company’s internal control over financial reporting because of a material weakness), appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2011.

 

/s/    Deloitte & Touche LLP

 

San Diego, California

March 20, 2012

GenMark Diagnostics, Inc. Reports

Also read